Intro

Quick Procedure

A quick, typically painless same-day surgery to help you achieve better vision.

Pre-Op Eye Exam

Before you schedule your EVO ICL procedure, your doctor will perform a series of standard tests to measure your eye’s unique characteristics for the procedure. Once your doctor determines that the EVO ICL is a good option for you, they will educate you about the procedure and what to expect both during and after the procedure.

Getting Your EVO ICLs

When you arrive for your procedure your doctor will administer eye drops to dilate your pupils as well as anaesthetise your eyes.

Small Opening

To prepare for the implant your doctor will create a small opening in your cornea to insert the EVO ICL lens. The procedure is painless because of the numbing medication.

Lens Insertion & Positioning

The EVO ICL lens then can be folded and inserted through the small incision your doctor has made. Once the lens is inserted the doctor will make any necessary adjustments to ensure proper positioning in the eye.

Returning Home

At this point, the procedure is over and many patients will have improved vision nearly immediately. Your doctor will prescribe eye drops intended to aid in the healing process following the procedure. You will need someone to drive you home. Your doctor will tell you when your vision allows driving.

Real Life Stories From Real Life Patients

The moment I opened my eyes after the EVO ICL procedure, I was impressed by how good my vision already was. I wish someone had told me sooner about this type of procedure and that I was suitable to have it.

Joanne Gibbons | Optician

The versatility and just the incredible technology behind it and the crystal-clear vision that I've been able to experience following the procedure, it has been a world of difference in a million ways, day-to-day. It has been absolutely worth it.

Jordan Rogers | Patient Care Specialist

My vision is not only the sharpest it has ever been in my life... it's the fact that everywhere I look, my vision is just super crisp... I just see so much better than I've ever seen before.

Dr. Joseph J. Allen | Optometrist

The world has evolved. So has vision correction.

Eyecare Professionals | Meet the eyecare professionals who chose EVO ICL for themselves.

I had my first opportunity to put my ICLs eyes to the test recently in the Amazon rainforest, and it couldn't have been more exciting to be able to spot rare species better than ever.

Phil Torres | Entomologist, TV Show Host

I feel like a big part of health is using what your body already has. ICLs is in line with that because it’s keeping your eye completely intact. My eye is still my eye.

Eve Torres Gracie | Jiu Jitsu Instructor

These patients have ICL lenses and were sponsored by STAAR Surgical.

4 Million+

Lenses Distributed

99.4%

of people surveyed would have the procedure again¹

Important Safety Information for EVO/EVO+ ICL

The EVO/EVO+ ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with up to 6 D of astigmatism for patients who are 21 to 60 years of age and for patients 21 years of age or older who have been treated with an intraocular lens. Implantation of the EVO/EVO+ ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse events: additional surgeries, cataract formation, transient or persistent loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, corneal swelling, conjunctival irritation, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO/EVO+ ICL dislocation, macular edema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO/EVO+ ICL surgery you should have a complete eye examination and talk with your eye care professional about the EVO/EVO+ ICL procedure, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

References

Locale Switcher

Europe

AustriaBelgium - DutchBelgium - FrenchFranceGermanyItalyNetherlandsNorwayPortugalSpainSwedenSwitzerlandUK & Ireland

North America

CanadaCanada - FrenchMexicoUnited StatesUnited States - 中文

Latin America

Spanish (Mexico)Portuguese (bra

North Africa

ArabicFrench

Middle East

Middle East عربىMiddle East - فارسيMiddle East - EnglishTest - English

Asia Pacific

AustraliaChina - 中国IndiaJapan - 日本New ZealandS. Korea - 대한민국South East Asia

References

1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.

2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.

3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clin Ophthalmol. 2022;16:1541-53.

4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.

5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2321-2328.

6. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. Eur J of Ophthalmol. 2007; 17(1): pp. 1-6.

7. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg., Volume 26 , Issue 9 , 1326 - 1331.

8. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.